Top compounds associated with response to AL031664.1


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.26 1e-07
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.21 3e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA Teniposide CTRPv2 pan-cancer AAC -0.13 0.001
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV